ArticleCancer medicine2025

METTL3, an Independent Adverse Prognostic Factor for AML, Promotes the Development of AML by Modulating the PGC-1α-MAPK Pathway and PGC-1α-Antioxidant System Axis.

Yuqian Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.